Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07082699

The Efficacy of Antegrade and Retrograde Enemas Management in Low Anterior Resection Syndrome and Improving the Rate of Ileostomy Reversal

Anterior rectal resection has become the primary surgical treatment for rectal cancer. However, studies have reported that up to 80%-90% of patients who undergo anterior rectal resection experience varying degrees of defecation dysfunction after surgery, such as frequent bowel movements, urgent bowel movements, and faecal incontinence, known as low anterior resection syndrome (LARS). This can lead to a decline in quality of life after surgery and even partial loss of social functioning.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • According to the NCCN guidelines for the pathological diagnosis of rectal cancer, the patient has primary rectal adenocarcinoma;
  • Age ≥ 18 years;
  • Previously underwent rectal resection with prophylactic ileostomy via laparoscopy, robotics, or open surgery;
  • Expected to undergo ileostomy reversal surgery within 1-2 months;
  • Possesses normal cognitive and communication abilities;
  • Voluntarily participates in this study and has signed an informed consent form.

Exclusion criteria

  • American Society of Anesthesiologists (ASA) classification III or higher;
  • Concurrent inflammatory bowel disease, Crohn's disease, or other intestinal diseases;
  • Mental disorders, long-term use of psychiatric drugs;
  • Contraindications to enemas.

Treatment and study plan

antegrade enema

Other

Introduce saline at a flow rate of 40 ml/minute through the distal end of the ileostomy. The initial enema volume is approximately 500 ml, with a maximum of 1000 ml. Perform twice weekly for one month.

retrograde enema

Other

Introduce saline at a flow rate of 40 ml/minute through the anus. The initial enema volume is approximately 500 ml, with a maximum of 1000 ml. Perform twice weekly for one month.

Primary outcomes

  1. Success rate of ileostomy reversal

    Time frame: Two months after the last enema

  2. low anterior resection syndrome score (LARS score)

    Time frame: Evaluations were conducted one day before enema, one month after enema, one month, two months, three months, and six months after stoma closure.

    The LARS score consists of five components and the total score, ranging from 0 to 42. Severity levels are categorized as follows: no LARS (0-20 points), minor LARS (21-29 points), and major LARS (30-42 points).

Secondary outcomes

  1. quality of sleep

    Time frame: Evaluations were conducted one day before enema, one month after enema, one month, two months, three months, and six months after stoma closure.

    Quality of sleep was evaluated by Pittsburgh Quality Index (PSQI). The PSQI assesses a participant's sleep quality in the previous month using 18 items divided into 7 components. Each component is graded between 0 and 3. The total score is 0-21, with higher scores indicating poorer sleep quality.

  2. bowel function

    Time frame: one month, two months, three months, and six months after stoma closure.

    The Memorial Sloan-Kettering Cancer Center Bowel Function Instrument (MSKCC BFI) is used to assess bowel function. This questionnaire comprises three dimensions, totaling 18 items. The total scale score ranged from 18 to 90, with higher scores indicating better bowel function.

  3. cancer patients' quality of life

    Time frame: one month, two months, three months, and six months after stoma closure.

    The quality of life was assessd by the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire-Colorectal Cancer 29 (EORTC QLQ-CR29). The scale includes 4 functional domains, 19 symptom domains, and 6 stoma-related items. Each item, except for item 18 (which indicates the presence or absence of a stoma), is rated on a 4-point scale: 'not at all,' 'a little,' 'quite a bit,' and 'very much,' corresponding to scores of 1 to 4, respectively. Scores are converted into standardized values ranging from 0 to 100 using polarization. Higher scores in the functional domains indicate better function, whereas higher scores in the symptom domains reflect more severe symptoms.

Other outcomes

  1. The psychosocial adjustment level of patients with enterostomy

    Time frame: Evaluate one day before starting enemas and one month after enemas before performing stoma closure.

    The psychosocial adjustment level of patients with enterostomy were evaluated using the Ostomy Adjustment Inventory-20 (OAI-20). OAI-20 adopts a 5-level Likert scoring method, forward scores range from 0 (strongly disagree) to 4 (strongly agree), while reverse scores range from 4 (strongly disagree) to 0(strongly agree). Total scores range from 0 to 80, where scores <40 indicate low psychosocial adjustment, scores between 40 and 59 indicate medium psychosocial adjustment, and scores ≥60 indicate high psychosocial adjustment levels.

  2. The Stoma-Specific Quality of Life

    Time frame: Evaluate one day before starting enemas and one month after enemas before performing stoma closure.

    The Stoma-Specific Quality of Life-Questionnaire (Stoma QoL) was designed specifically for patients with ostomy and consists of 20 entries, each of which is divided into 4 levels: always, sometimes, rarely, never, with a score ranging from 1 to 4. The ratings range from 20 to 80, with higher levels indicating higher HRQoL.

  3. Observation chart for anal excretion and irritation symptoms during ostomy (self-made)

    Time frame: Evaluate one day before starting enemas and one month after enemas before performing stoma closure

    This was designed to assess anal feces and discomfort sensations in stoma patients during their stoma time. The questionnaire consisted of four main questions dealing with frequency of defecation, perception of bowel movement, sensation of irritation in the anal region, and the patient's reaction to irritants. These four specific questions as follow:

    • In the last week, how often have you felt discharge oozing from around your anus?
    • In the last week, how often have you felt a bowel movement around your anus?
    • In the last week, how often have you felt irritation in your bowel movements?
    • Do you experience skin irritation or discomfort from anal discharge? (five-point scale: "very", "rather", "generally", "somewhat", "not at all")

Sponsors and collaborators

Lead sponsor

Sichuan Cancer Hospital and Research Institute

Other

Registry information

Official study title

The Efficacy of Antegrade and Retrograde Enemas in the Management of Low Anterior Resection Syndrome and Improving the Rate of Ileostomy Reversal: A Single-Centre, Prospective Randomised Controlled Trial

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jul 24, 2025
Registry last updated
Jul 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.